title: Metabolic reprogramming: a cancer hallmark even warburg did not anticipate.
abstract: Cancer metabolism has long been equated with aerobic glycolysis, seen by early biochemists as primitive and inefficient. Despite these early beliefs, the metabolic signatures of cancer cells are not passive responses to damaged mitochondria but result from oncogene-directed metabolic reprogramming required to support anabolic growth. Recent evidence suggests that metabolites themselves can be oncogenic by altering cell signaling and blocking cellular differentiation. No longer can cancer-associated alterations in metabolism be viewed as an indirect response to cell proliferation and survival signals. We contend that altered metabolism has attained the status of a core hallmark of cancer.
authors.affiliation: Cancer Biology and Genetics Program, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.
authors.forename: Patrick S
authors.initials: PS
authors.lastname: Ward
authors.forename: Craig B
authors.initials: CB
authors.lastname: Thompson
mesh_terms: D017398:Alternative Splicing; D014408:Biomarkers, Tumor / Q000378:metabolism*; D002454:Cell Differentiation; D049109:Cell Proliferation; D044127:Epigenesis, Genetic; D019143:Evolution, Molecular; D006801:Humans; D007527:Isoenzymes / Q000378:metabolism / Q000502:physiology; D008928:Mitochondria / Q000502:physiology; D008954:Models, Biological; D009369:Neoplasms / Q000235:genetics / Q000378:metabolism* / Q000473:pathology; D016271:Proto-Oncogene Proteins c-myc / Q000378:metabolism; D015398:Signal Transduction
chemical_list: D014408:Biomarkers, Tumor; D007527:Isoenzymes; D016271:Proto-Oncogene Proteins c-myc